Table 2

- Malignancy rate in different Bethesda III subcategories.

Bethesda III SubcategoryBenign (n=97)Malignant (n=96)P-valuePTC (n=83)FTC (n=13)
Architectural atypia44 (49.4%)45 (50.6%)0.24036 (80.0%)9 (20.0%)
Cytologic and architectural atypia20 (66.7%)10 (33.3%)7 (70.0%)3 (30.0%)
Cytologic atypia29 (44.6%)36 (55.4%)35 (97.2%)1 (2.8%)
Hürthle cell AUS4 (44.4%)5 (55.6%)5 (100.0%)0 (0.0%)

PTC: papillary thyroid carcinoma, FTC: follicular thyroid carcinoma, AUS: Atypia of an undetermined significance